ArticleHealth research policy and systems2025
Advancing the women's health strategy: a policy lab aimed at improving effective management of hyperemesis gravidarum.
Article in Health research policy and systems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyperemesis gravidarum (HG) is associated with morbidity and mortality which can be exacerbated by difficulties accessing guideline-recommended treatment. Improving outcomes for women with HG through policy and practice fulfils the vision of the Women's Health Strategy for England. We aimed to align with the Women's Health Strategy by addressing barriers to evidence-based care and to improve effective management of HG.
methodsA Policy Lab was held in Central London in February 2023 guided by the King's Policy Institute eight-step process for delivery.
resultsThe Policy lab brought together 22 key stakeholders from a range of backgrounds in clinical medicine, academia, policy, Royal Colleges and patient representatives. The challenges and opportunities for improving the quality and consistency of care for women with HG were discussed. A long list of 26 possible actions were determined of which five have been implemented and a further six are currently being implemented. Key outcomes include an update on the Royal College of Obstetricians and Gynaecologist (RCOG) guideline on Nausea and Vomiting to enable standardized care across the healthcare settings, awareness of the condition being raised through a number of high impact conferences/educational meetings and HG now being recognized in the Women's Health Strategy. The Department of Health and Social Care has convened a group focussed on implementing the recommendations of the lab.
conclusionsThis Policy Lab brought together key stakeholders to determine strategies to enhance the Women's Health Strategy and to ensure all women with HG are able to access guideline-recommended evidence-based treatment. Outputs of the Lab to date include updating the RCOG guideline with the support of Royal Colleges from all relevant care sectors to enable standardized practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.